menu search

Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update

Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
FLORHAM PARK, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced financial results for the second quarter ended June 30, 2023 and provided a corporate update. Second Quarter and Recent Corporate Highlights In June, the […] The post Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate U... Read More
Posted: Aug 14 2023, 12:40
Author Name: forextv
Views: 022190

Search within

Pages Search Results: